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Glucocorticoid intracellular metabolism, catalyzed by the two isozymes of 11 -hydroxysteroid 
dehydrogenase (11 -HSD), determines the corticosteroid action on target tissues.1 11 -HSD1 
functions as a reductase in most cells and catalyzes the regeneration of active glucocorticoids 
thereby amplifying their action. This isozyme is wildely expressed in liver, adipose tissue, 
muscle, pancreatic islets, and adult brain. 11 -HSD2 is a high-affinity dehydrogenase and 
inactivates cortisol and corticosterone to the inert product, cortisone. Cortisone in turn can be 
reactivated through reduction by 11 -HSD1 (Figure 1). The 11 -HSD2 isozyme is highly 
expressed in the distal nephron and, as we learn here, in the nucleus tractus solitarius (NTS). 11 
-HSD2 serves to protect the mineralocorticoid receptor (MR) from occupation by cortisol or 
corticosterone (Figure 2).  
The development of this complicated arrangement of receptors and steroid ligands has 
been elucidated by molecular evolutionary biologists. The vertebrate ancestral corticoid receptor 
has been tracked back to 450 million years ago, its sequence has been “resurrected”, and 
crystallized.2 Investigators have identified the specific set of historical mutations occuring during 
evollution that recapitulated the GR’s hormone specificity for corisol from an MR-like ancestor, 
suggesting that back then salt was more important than sugar. Interestingly, the MR is older than 
the GR. 
In mammals, the adrenal cortex synthesizes aldosterone, the major mineralocorticoid, 
from the zona glomerulosa and the glucocorticoids, cortisol and corticosterone, from the zona 
fasciculata and zona reticularis.1 The corticosteroids are bound in the circulation primarily to 
corticosteroid binding protein. The corticosteroid molecules are highly lipophilic, are believed to 
readily perimeate biological membranes, and then activate intracellular receptors. The 
glucocorticoid receptor (GR) has a lower affinity for corticosteroids than the mineralocorticoid 
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receptor (MR). Both receptors bind 11 hydroxycorticosteroids, while the binding of the 11-
keto forms is negligible. On binding to GR or MR, the receptors are released from chaperone 
proteins and can translocate into the nucleus where they bind on target genes. A surprizing 2% of 
the human genome is said to be regulated by glucocorticosteroids. Membrane receptors also 
exist. The MR exhibits a more restricted tissue distribution and resides particularly in the kidney, 
colon, salivary glands, and parts of the central nervous system. The GR is more widely expressed 
and at higher levels than the MR. 
The adrenal cortex secretes nanomolar concentrations of cortisol but only picomolar 
concentrations of aldosterone. The MR binds cortisol and aldosterone with similar affinity in 
vitro; however, in the presence of 11 -HSD2, cortisol is inactivated to cortisone in vivo, 
enabling the MR in kidney and wherever else 11 -HSD2 resides, to bind solely with 
aldosterone. At some sites such as the hippocampus where 11 -HSD2 is absent, the MR signals 
primarily by binding to cortisol. 
Glucocorticoids have profound effects on brain development and adult CNS function.3 
Elevated hippocampal and neocortical 11 -HSD1 is observed with ageing and causes cognitive 
decline in humans. Its deficiency prevents the emergence of cognitive defects with age. In 
contrast, the major central nervous system effects of 11 -HSD2 occur in development, as 
expression of 11 -HSD2 is high in fetal brain and placenta. Deficient feto-placental 11 -HSD2 
results in a life-long phenotype of anxiety and cardiometabolic disorders, consistent with early-
life glucocorticoid programming. Geerling et al discovered a novel group of neurons in the NTS 
that express 11 -HSD2, which makes them selectively responsive to aldosterone.4 MR activation 
at this site paralleled salt appetite. In the rat brain, aldosterone-selective areas have also been 
identified that are important to blood presssure regulation, including the NTS, subfornical organ, 
and hypothalamic regions. For instance, Janiak et al found that MR central nervous system 
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binding sites were necessary for the development of deoxycorticosterone acetate (DOCA)-salt 
hypertension.5  
Modern molecular technology sheds light on the role of specific MR signaling in the 
central nervous system. In this issue of Circulation, Evans and colleagues report on conditional 
deletion of the gene encoding 11 -HSD2 (Hsd11b2) in the brain. Hsd11b2 floxed mice were 
generated on a C57BL6 background and were bred with transgenic mice expressing Cre 
recombinase under the control of a rat nestin promoter.6 Nestin is an intermediate filament 
protein expressed in the central and peripheral nervous system. Hsd11b2 brain-knockout 
(Hsd11b2BKO) mice had normal basal blood pressures, serum electrolytes, and circulating 
corticosteroids. However, when offered saline to drink, they drank three times as much fluid as 
controls and developed salt-sensitive hypertension. The authors measured blood pressure with 
radiotelemetry and a consistent 10 mm Hg difference in blood pressure was recorded between 
Hsd11b2BKO and control mice. When salt was withdrawn, the blood pressure increase 
disappeared within one week. When given spironolactone, the salt preference of Hsd11b2BKO 
was reduced by about 30%.  The authors gave Hsd11b2BKO and control mice exposed to salt 
dexamethasone to reduce endogenous glucocorticoid production. This maneuver raised blood 
pressure in contol mice but had little influence on blood pressure of Hsd11b2BKO. The authors 
could detect no volume expansion or failure in salt elimination in Hsd11b2BKO subjected to a 
high-salt intake. However, pressor responses to phenylephrine were enhanced and resultant 
baroreflex regulation was impaired in the mice.  
What are the implications of these findings? The authors suggest that 11 -HSD2 neurons 
must exist that integrate salt appetite and blood pressure via an MR-dependent pathway. They 
then suggest that central MR antagonism could increase compliance to a low-salt diet and 
facilitate management of hypertension. How well does spironolactone cross the blood-brain 
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barrier? Corticosteroid analogs are highly lipophilic and presumably cross cell membranes; 
however, there is a role for membrane transporters, such as ABCB1, the multidrug-resistant/p-
glycoprotein that is particularly effective at the blood-brain barrier. For instance, the p-
glycoprotein minimises the access of dexamethasone into the brain.7 The spironolactone active 
metabolite, canrenone, has been studied in detail and crosses the blood-brain barrier fairly well.8 
The authors implanted a 30 mg spironolactone subcutaneously into their mice. Any similarity to 
doses used in humans is uncertain, although the present findings are suffiently stimulating to 
warrant studies on salt appetite in humans.9  
The presence of an enzymatic mechanism protecting the MR and the effects on salt 
appetite and blood pressure with its absence, underscores the notion that aldosterone regulates 
salt appetite independent of angiotensin II-related effects. The data also have relevance to salt 
resistance, since the mice with an intact enzymatic barrier could increase their salt intake five-
fold without effects on blood pressure. Aldosterone is believed to activate the same signaling and 
effector mechanisms in the brain as in the kidney including the MR, the serum and 
glucocorticoid-induced kinase SGK1, the ubiquitin ligase NEDD4-2, and the epithelial sodium 
channel ENaC.10 The latter also mediates the gustatory salt sensing in the tongue, which is 
required for the manifestation of increased salt intake. Effects of aldosterone on both the brain 
and kidney synergize with the effects of angiotensin II. Thus, the current findings provide a 
unifying connection between MR activation in the central nervous system, salt appetite, and 
blood pressure regulation.  
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Figure 1. 11 -HSD1 is predominantly a reductase that catalyzes the NADPH-dependent 
reduction of cortisone to the active glucocorticoid, cortisol. 11 -HSD2 functions mainly as an 
NADP-dependent dehydrogenase, inactivating cortisol to cortisone. 
Figure 2. 11 -HSD2 catalyzes the rapid inactivation of cortisol (compound F) to cortisone 
(compound E) in the kidney and the nucleus tractus solitarius. Cortisol is intended for the 
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glucocorticoid receptor (GR). However, 11 -HSD2 is absent in the hippocampus, which 
expresses the mineralocorticoid receptor (MR). At this site, the MR can be activated by cortisol. 
Since the GR has a 10-fold lower affinity for cortisol than the MR, 11 -HSD1 provides a 
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